Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Urology
|
April 28, 2007
Epidemiologic issues in interstitial cystitis
J Kellogg Parsons, Karlheinz Kurth, Grannum R Sant
The Journal of Urology
|
June 11, 2005
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials
Richard J Sylvester, Adrian P M van der Meijden, J Alfred Witjes, et al.
European Urology
|
June 21, 2002
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies
Maurizio Brausi, Laurence Collette, Karlheinz Kurth, et al.
European Urology
|
January 31, 2006
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials
Richard J Sylvester, Adrian P M van der Meijden, Willem Oosterlinck, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Urology
|
April 28, 2007
Epidemiologic issues in interstitial cystitis
J Kellogg Parsons, Karlheinz Kurth, Grannum R Sant
The Journal of Urology
|
June 11, 2005
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials
Richard J Sylvester, Adrian P M van der Meijden, J Alfred Witjes, et al.
European Urology
|
June 21, 2002
Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies
Maurizio Brausi, Laurence Collette, Karlheinz Kurth, et al.
European Urology
|
January 31, 2006
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials
Richard J Sylvester, Adrian P M van der Meijden, Willem Oosterlinck, et al.
Page
of 1